DWEK RAYMOND
SEC CIK 1231617 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | Dir | 1,750 | — | $5.00M | 41 | 2021-11-08 | 2025-04-21 |
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $841.11M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
DWEK RAYMOND made no open-market trades at UTHR in the last 12 months.
Transactions 41
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-04-22 | 2025-04-21 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | S - Sale+OE | $285.57 | -3,000 | 1,750 | -63% | -$856.7K |
| DT | 2025-04-22 | 2025-04-21 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $175.43 | +3,000 | 4,750 | +171% | +$526.3K |
| DT | 2025-04-15 | 2025-04-14 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | S - Sale+OE | $285.16 | -3,000 | 1,750 | -63% | -$855.5K |
| DT | 2025-04-15 | 2025-04-14 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $175.43 | +3,000 | 4,750 | +171% | +$526.3K |
| DT | 2025-04-08 | 2025-04-07 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | S - Sale+OE | $284.55 | -4,000 | 1,750 | -70% | -$1.14M |
| DT | 2025-04-08 | 2025-04-07 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $175.43 | +4,000 | 5,750 | +229% | +$701.7K |
| DM | 2024-08-05 | 2024-08-02 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | S - Sale+OE | $325.35 | -5,000 | 1,850 | -73% | -$1.63M |
| D | 2024-08-05 | 2024-08-02 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $175.43 | +5,000 | 6,750 | +286% | +$877.1K |
| D | 2024-04-23 | 2024-04-22 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $88.03 | +3,000 | 4,750 | +171% | +$264.1K |
| D | 2024-04-23 | 2024-04-22 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $234.06 | -3,000 | 1,750 | -63% | -$702.2K |
| D | 2024-04-16 | 2024-04-15 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $235.08 | -3,000 | 1,750 | -63% | -$705.2K |
| D | 2024-04-16 | 2024-04-15 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $88.03 | +3,000 | 4,750 | +171% | +$264.1K |
| D | 2024-04-09 | 2024-04-08 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $88.03 | +4,000 | 5,750 | +229% | +$352.1K |
| D | 2024-04-09 | 2024-04-08 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $236.96 | -4,000 | 1,750 | -70% | -$947.8K |
| D | 2023-07-07 | 2023-07-07 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $0.00 | +1,750 | 1,750 | New | $0 |
| D | 2023-04-24 | 2023-04-21 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $63.90 | +2,000 | 2,000 | New | +$127.8K |
| D | 2023-04-24 | 2023-04-21 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $230.76 | -2,000 | 0 | -100% | -$461.5K |
| D | 2023-04-18 | 2023-04-14 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $228.72 | -2,000 | 0 | -100% | -$457.4K |
| D | 2023-04-18 | 2023-04-14 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $63.90 | +2,000 | 2,000 | New | +$127.8K |
| D | 2023-04-12 | 2023-04-10 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $63.90 | +3,000 | 3,000 | New | +$191.7K |
| D | 2023-04-12 | 2023-04-10 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $223.07 | -3,000 | 0 | -100% | -$669.2K |
| D | 2022-11-08 | 2022-11-07 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $88.03 | +5,000 | 5,000 | New | +$440.1K |
| D | 2022-11-08 | 2022-11-07 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $266.80 | -5,000 | 0 | -100% | -$1.33M |
| D | 2022-09-12 | 2022-09-09 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $63.90 | +3,000 | 3,000 | New | +$191.7K |
| D | 2022-09-12 | 2022-09-09 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $223.48 | -3,000 | 0 | -100% | -$670.4K |
| D | 2022-07-11 | 2022-07-11 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | S - Sale+OE | $241.29 | -2,160 | 0 | -100% | -$521.2K |
| D | 2022-07-11 | 2022-07-08 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $0.00 | +2,160 | 2,160 | New | $0 |
| D | 2022-05-26 | 2022-05-26 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $224.78 | -5,000 | 2,000 | -71% | -$1.12M |
| D | 2022-05-26 | 2022-05-26 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $63.90 | +5,000 | 7,000 | +250% | +$319.5K |
| D | 2022-05-06 | 2022-05-05 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $48.11 | +2,000 | 2,000 | New | +$96.2K |
| D | 2022-05-06 | 2022-05-05 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $186.99 | -2,000 | 0 | -100% | -$374.0K |
| D | 2022-04-29 | 2022-04-28 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $48.11 | +2,000 | 2,000 | New | +$96.2K |
| D | 2022-04-29 | 2022-04-28 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $179.34 | -2,000 | 0 | -100% | -$358.7K |
| D | 2022-04-22 | 2022-04-21 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $48.11 | +2,000 | 2,000 | New | +$96.2K |
| D | 2022-04-22 | 2022-04-21 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $190.22 | -2,000 | 0 | -100% | -$380.4K |
| D | 2022-04-15 | 2022-04-14 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $48.11 | +2,000 | 2,000 | New | +$96.2K |
| D | 2022-04-15 | 2022-04-14 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $191.91 | -2,000 | 0 | -100% | -$383.8K |
| D | 2022-04-08 | 2022-04-07 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $48.11 | +2,000 | 2,000 | New | +$96.2K |
| D | 2022-04-08 | 2022-04-07 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $190.11 | -2,000 | 0 | -100% | -$380.2K |
| D | 2021-11-08 | 2021-11-08 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | D - Sale to Iss | $202.09 | -3,000 | 0 | -100% | -$606.3K |
| D | 2021-11-08 | 2021-11-08 | UTHR | UNITED THERAPEUTICS Corp | DWEK RAYMOND | Dir | M - OptEx | $48.11 | +3,000 | 3,000 | New | +$144.3K |
Purchase Sale Sale after option exercise All abbreviations